Explore insights and strategies for managing TK2d long-term.
-
-
Study links shorter telomeres to mitochondrial DNA depletion disorders
-
Targeted gene therapy reverses cardiomyopathy in mitochondrial disease
-
Mitochondrial DNA release may trigger inflammation in TK2d
-
Rare Patient Voice rewards patients and caregivers for sharing their insights
-
First treatment for TK2d may soon be approved in Europe
-
New research examines Twinkle disease and its link to TK2 deficiency